Pinpointing the cellular mechanisms of cancer

Molecule featured

Daniel HarkiKaylee SLed by Daniel Harki, Ph.D., and Kaylee Schwertfeger, Ph.D., the Cellular Mechanisms of Cancer program brings together some 65 researchers from the Masonic Cancer Center who are focused on the cellular aspects of malignant cancer progression. 

With Masonic support, the group has continued to lead impactful research over the last year with the overarching goal of translating discoveries into novel cancer therapies. Examples of their recent studies focus on everything from identifying potential new cellular culprits in breast cancer, to overcoming resistance to prostate cancer therapy. Masonic funding has also helped the group leverage larger new awards for their research from the NIH and other national organizations. 

The Cellular Mechanisms program places high priority on mentoring talented junior faculty. Program leaders meet with new group members throughout the year, and new members present their work in program meetings. Additionally, the program links members to opportunities to participate in the University’s Epigenetics Consortium and the Masonic Cancer Center’s Translational Working Groups. 


Lisa Peterson
Chronic obstructive pulmonary diseases (COPDs) such as chronic bronchitis and emphysema make it difficult to breathe and can cause irreversible... Read more
Turesky researchers
Robert Turesky, inaugural holder of the Masonic Chair in Cancer Causation, is on a mission: to get cancer-causing chemicals in food, drinks, and... Read more
Andrew Nelson
Andrew Nelson, M.D., Ph.D., Masonic Scholar and laboratory medicine and pathology faculty member, is dedicated to understanding the biological... Read more